The upregulation of KLF16 had a positive correlation with SF3B4 mRNA level in the ccRCC tissues (Fig. 5P), with high expression of KLF16 in ccRCC patients having a significantly poorer survival outcome (Fig. 5Q). This evidence concerns the gene SF3B4 and nonpapillary renal cell carcinoma.